Watchlist Price Alert

Achieve Life Sciences Inc... (ACHV)

NASDAQ: ACHV · Real-Time Price · USD

3.16

0.18 (6.04%)

At close: Jun 18, 2025, 3:59 PM

3.01

-4.75%

After-hours: Jun 18, 2025, 05:54 PM EDT

6.04% (1D)

Bid	2.98
Market Cap	109.6M
Revenue (ttm)	n/a
Net Income (ttm)	-46.16M
EPS (ttm)	-1.35
PE Ratio (ttm)	-2.34
Forward PE	-3.86
Analyst	Buy

Ask	3.38
Volume	184,637
Avg. Volume (20D)	254,677.4
Open	2.99
Previous Close	2.98
Day's Range	2.99 - 3.18
52-Week Range	1.84 - 5.31
Beta	1.64

About ACHV

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol ACHV

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ACHV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

4 months ago

+15.74%

Achieve Life Sciences shares are trading higher af... Unlock content with Pro Subscription

News

1 week ago · https://www.defenseworld.net

Squarepoint Ops LLC Buys Shares of 17,519 Achieve Life Sciences, Inc. (NASDAQ:ACHV)

Squarepoint Ops LLC bought a new stake in shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing...

2 weeks ago · seekingalpha.com

Achieve Life Sciences: FDA Approval Not Assured, But Valuation Justifies Risk

Achieve Life Sciences (ACHV) is positioned for growth with its lead smoking cessation therapy, cytisinicline, advancing through late-stage clinical trials. The company addresses a significant unmet ne...

1 month ago · seekingalpha.com

Achieve Life Sciences, Inc. (ACHV) Q1 2025 Earnings Call Transcript

Achieve Life Sciences, Inc. (NASDAQ:ACHV ) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Nicole Jones - Investor Relations Rick Stewart - Chief Executive Officer Cindy ...